Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain
Xiaomin Ni, Martin Schröder, Vincent Oliéric, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 4, pp. 603-609
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

A structural view of the SARS-CoV-2 virus and its assembly
Nathan Hardenbrook, Peijun Zhang
Current Opinion in Virology (2021) Vol. 52, pp. 123-134
Open Access | Times Cited: 65
Diastereoselective Decarboxylative Alkynylation of Anomeric Carboxylic Acids Using Cu/Photoredox Dual Catalysis
Mingxiang Zhu, Samir Messaoudi
ACS Catalysis (2021) Vol. 11, Iss. 10, pp. 6334-6342
Open Access | Times Cited: 57
The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses
Anthony K. L. Leung, Diane E. Griffin, Jürgen Bosch, et al.
Pathogens (2022) Vol. 11, Iss. 1, pp. 94-94
Open Access | Times Cited: 32
Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening
Anu Roy, Yousef M. Alhammad, Peter R. McDonald, et al.
Antiviral Research (2022) Vol. 203, pp. 105344-105344
Open Access | Times Cited: 30
Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery
Zhonglei Wang, Liyan Yang, Xian‐En Zhao
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4684-4701
Open Access | Times Cited: 36
A molecular toolbox for ADP-ribosyl binding proteins
Sven T. Sowa, Albert Galera‐Prat, Sarah Wazir, et al.
Cell Reports Methods (2021) Vol. 1, Iss. 8, pp. 100121-100121
Open Access | Times Cited: 33
Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir
Paul Andrei Negru, Andrei-Flavius Radu, Cosmin Mihai Vesa, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112700-112700
Open Access | Times Cited: 27
Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2
Ashleigh Shannon, Bruno Canard
Antiviral Research (2022) Vol. 210, pp. 105501-105501
Open Access | Times Cited: 25
Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors
M. Schuller, Tryfon Zarganes‐Tzitzikas, James M. Bennett, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 324-324
Open Access | Times Cited: 14
Derivatives of MOPS: promising scaffolds for SARS coronaviruses Macro domain‐targeted inhibition
Oney Ortega Granda, Karine Alvarez, Benjamin Morin, et al.
FEBS Journal (2025)
Open Access
β-Carboline alkaloids induce structural plasticity and inhibition of SARS-CoV-2 nsp3 macrodomain more potently than remdesivir metabolite GS-441524: computational approach
Yusuf Oloruntoyin Ayipo, Yahaya Sani Najib, Halimah Funmilayo Babamale, et al.
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 503-517
Open Access | Times Cited: 24
Intracellular mono-ADP-ribosyltransferases at the host–virus interphase
Bernhard Lüscher, Maud Verheirstraeten, Sarah Krieg, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 18
Recent advances in the synthesis of poly (ADP-ribose)
Yidan Wu, Tang Li, Qiang Liu
Bioorganic & Medicinal Chemistry (2025) Vol. 125, pp. 118202-118202
Closed Access
Crystal structure and biochemical activity of the macrodomain from rubella virus p150
Guido A. Stoll, Nikos Nikolopoulos, Haoming Zhai, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access | Times Cited: 3
Host ADP-ribosylation and the SARS-CoV-2 macrodomain
Nícolas C. Hoch
Biochemical Society Transactions (2021) Vol. 49, Iss. 4, pp. 1711-1721
Open Access | Times Cited: 19
Remdesivir: Quo vadis?
Erik De Clercq
Biochemical Pharmacology (2021) Vol. 193, pp. 114800-114800
Open Access | Times Cited: 19
Artificial Neural Network-Based Study Predicts GS-441524 as a Potential Inhibitor of SARS-CoV-2 Activator Protein Furin: a Polypharmacology Approach
M. Dhanalakshmi, Kajari Das, Medha Pandya, et al.
Applied Biochemistry and Biotechnology (2022) Vol. 194, Iss. 10, pp. 4511-4529
Open Access | Times Cited: 13
A Fluorescence Polarization Assay for Macrodomains Facilitates the Identification of Potent Inhibitors of the SARS-CoV-2 Macrodomain
Ananya Anmangandla, Sadhan Jana, Kewen Peng, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 5, pp. 1200-1207
Open Access | Times Cited: 7
An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors
Joseph J. O’Connor, Dana Ferraris, Anthony R. Fehr
Pathogens (2023) Vol. 12, Iss. 10, pp. 1221-1221
Open Access | Times Cited: 7
Potential targets of severe acute respiratory syndrome coronavirus 2 of clinical drug fluvoxamine: Docking and molecular dynamics studies to elucidate viral action
Saroj Kumar Panda, Parth Sarthi Sen Gupta, Malay Kumar Rana
Cell Biochemistry and Function (2022) Vol. 41, Iss. 1, pp. 98-111
Closed Access | Times Cited: 12
Structural and functional analyses of SARS-CoV-2 Nsp3 and its specific interactions with the 5’ UTR of the viral genome
Sofia Lemak, T. Skarina, Robert Flick, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Unraveling the structural and functional dimensions of SARS-CoV2 proteins in the context of COVID-19 pathogenesis and therapeutics
Aniruddh Jhanwar, Dipika Sharma, Uddipan Das
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134850-134850
Closed Access | Times Cited: 2
The search for inhibitors of macrodomains for targeting the readers and erasers of mono-ADP-ribosylation
Wei Fu, Huiqiao Yao, Mareike Bütepage, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 11, pp. 2547-2558
Closed Access | Times Cited: 15
Binding Adaptation of GS-441524 Diversifies Macro Domains and Downregulates SARS-CoV-2 de-MARylation Capacity
Aikaterini C. Tsika, Angelo Gallo, Nikolaos K. Fourkiotis, et al.
Journal of Molecular Biology (2022) Vol. 434, Iss. 16, pp. 167720-167720
Open Access | Times Cited: 9
Synthesis of Structural ADP-Ribose Analogues as Inhibitors for SARS-CoV-2 Macrodomain 1
Koen J. Rijpkema, M. Schuller, Miriam S. van der Veer, et al.
Organic Letters (2024) Vol. 26, Iss. 27, pp. 5700-5704
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top